National Research/$NRC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About National Research
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Ticker
$NRC
Sector
Primary listing
Employees
368
Headquarters
Website
NRC Metrics
BasicAdvanced
$374M
20.94
$0.77
0.46
$0.48
2.96%
Price and volume
Market cap
$374M
Beta
0.46
52-week high
$22.25
52-week low
$9.76
Average daily volume
106K
Dividend rate
$0.48
Financial strength
Current ratio
0.705
Quick ratio
0.492
Long term debt to equity
361.164
Total debt to equity
379.581
Dividend payout ratio (TTM)
62.38%
Interest coverage (TTM)
8.26%
Profitability
EBITDA (TTM)
33.956
Gross margin (TTM)
60.31%
Net profit margin (TTM)
12.78%
Operating margin (TTM)
19.82%
Effective tax rate (TTM)
26.74%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
13.35%
Return on equity (TTM)
58.28%
Valuation
Price to earnings (TTM)
20.941
Price to revenue (TTM)
2.676
Price to book
17.55
Price to tangible book (TTM)
-7.92
Price to free cash flow (TTM)
40.491
Free cash flow yield (TTM)
2.47%
Free cash flow per share (TTM)
0.4
Dividend yield (TTM)
2.96%
Forward dividend yield
2.96%
Growth
Revenue change (TTM)
-4.08%
Earnings per share change (TTM)
-35.42%
3-year revenue growth (CAGR)
-2.59%
10-year revenue growth (CAGR)
3.49%
3-year earnings per share growth (CAGR)
-18.47%
10-year earnings per share growth (CAGR)
1.60%
3-year dividend per share growth (CAGR)
-12.64%
10-year dividend per share growth (CAGR)
10.31%
Bulls say / Bears say
Total recurring contract value increased 2% sequentially in Q2 2025, marking a third consecutive quarter of TRCV growth and the fastest sequential growth rate since Q1 2021. (Business Wire)
Total recurring contract value rose sequentially in Q1 2025, representing a second straight quarter of growth, aided by accelerated sales force expansion. (Business Wire via StockTitan)
Excluding one-time executive compensation expenses, Q2 2025 adjusted EBITDA edged up to $10.3 million, with a 30.3% margin, highlighting disciplined cost controls. (Zacks Equity Research)
Q2 2025 revenue declined 3% year-over-year to $34.0 million, and first-half revenue fell 4%, as subscription services weakened across the client base. (SEC Filing)
Operating income dropped 82% year-over-year in Q2 2025 to $1.6 million, with the company posting a net loss of $0.1 million due to $6.6 million in one-time executive bonuses; operating margin contracted to 5% from 25% the prior year. (SEC Filing)
Total debt rose 68% year-over-year to $81.4 million as of June 30, 2025, increasing net leverage to 3.8× EBITDA—above the 3.5× covenant threshold—raising risks of covenant breaches and higher interest expense. (SEC Filing)
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
NRC Financial Performance
Revenues and expenses
NRC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept26
National Research
DividendEx-dividend
Oct10
National Research
DividendPayment
$0.12Per share
FAQs
What’s the current market cap for National Research stock?
National Research (NRC) has a market cap of $374M as of September 15, 2025.
What is the P/E ratio for National Research stock?
The price to earnings (P/E) ratio for National Research (NRC) stock is 20.94 as of September 15, 2025.
Does National Research stock pay dividends?
Yes, the National Research (NRC) stock pays dividends to shareholders. As of September 15, 2025, the dividend rate is $0.48 and the yield is 2.96%. National Research has a payout ratio of 62.38% on a trailing twelve-month basis.
When is the next National Research dividend payment date?
The next National Research (NRC) dividend payment is scheduled for October 10, 2025.
What is the beta indicator for National Research?
National Research (NRC) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.